HTP is a powerful, natural supplement that supports serotonin production, making it beneficial for mood enhancement, anxiety ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...
Microsoft is commemorating our 50-year anniversary by celebrating the achievements of our employees, customers and partners that have dreamt, built and used Microsoft technology as a force for good, ...
Invest in the best stocks under $50 with Interactive Brokers for fast trade execution. You don’t need thousands of dollars in the bank to get started investing. Just $50, or less, can help you ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results